GET THE APP

..

Journal of Health Education Research & Development

ISSN: 2380-5439

Open Access

Ossama Abdel-Kawy

Ossama Abdel-Kawy

Ossama Abdel-Kawy
Turkish Atomic Energy Authority, Egypt

Biography

Dr. Ossama AbdelKawy is currently a senior scientist at the Atomic Energy Authority (AEA), Egypt. He serves as well as a Biosafety Regional Advisor for the Division on Environmental Laws and Conventions, United Nations Environmental Programme (UNEP). Ossama is an interdisciplinary researcher and postgraduate lecturer with a background in Microbiology and Biosafety. He has represented Egypt and the scientific profession at numerous international forums and meetings. His research over the past ten years, at the Atomic Energy Authority, has focused on biosafety issues, development of concepts for environmental risk assessment and post-release monitoring of Genetically Modified Organisms (GMOs), Radiopharmaceuticals, Cancer detection and therapy, discrimination between septic and aseptic inflammations and receptors targeting. Ossama has particular expertise in developing national and international regimes for biotechnology and Biosafety in relation to biodiversity; access and benefit sharing arising from the utilization of genetic resources. Through numerous research and capacity building projects he is heavily engaged in developing countries in Africa and West Asia as an expert advisor in international capacity building projects related to biosafety (e.g. in the framework of the Cartagena-Protocol on Biosafety, UNEP GEF, etc.). Furthermore he is nominated as expert for the Ad-Hoc Technical Expert Group established by the United Nations Secretariat of Convention on Biological Diversity and mandated to draft international guidelines for conducting Risk Assessment and Risk Management of Living Modified Organisms.

Research Interest

Biosafety issues, development of concepts for environmental risk assessment and post-release monitoring of Genetically Modified Organisms (GMOs), Radiopharmaceuticals, Cancer detection and therapy, discrimination between septic and aseptic inflammations and receptors targeting.

arrow_upward arrow_upward